CGMs may revolutionise cardiovascular prevention for metabolically healthy individuals

A new review suggests continuous glucose monitors could play a pivotal role in preventing heart disease even in people without diabetes, by revealing blood sugar fluctuations that traditional tests might miss.

A review posted on Rapamycin News argues that continuous glucose monitors, or CGMs, could have a role in cardiovascular prevention even for people who do not have diabetes and would normally be classed as metabolically healthy. The authors describe the idea as a hypothesis rather than a proven strategy, but they say the case for looking beyond fasting glucose and HbA1c is growing stronger. Their central point is that blood sugar spikes after meals may matter even when average readings look normal.

That argument is supported, at least in part, by research showing that glucose responses to the same meal can differ sharply from one person to another. A study published in the Proceedings of the Nutrition Society found that an individual’s response to identical meals was fairly consistent, but there was wide variation between people. MDedge reported that factors including the gut microbiome, meal timing, sleep and recent activity can shape those responses, raising doubts about one-size-fits-all dietary advice.

The review also claims that the real damage may come from swings in glucose rather than from the average level alone. It points to laboratory findings suggesting that short-lived rises in blood sugar can trigger oxidative stress, reduce nitric oxide and promote inflammation in blood vessel walls soon after eating. On that reading, a fasting glucose test or HbA1c result may miss a pattern that a CGM can reveal: repeated post-meal spikes inside the conventional normal range.

From there, the authors build a staged programme centred on CGM use. They suggest a short baseline period, followed by personalised diet changes, then supervised fasting, and finally, for some higher-risk people, off-label use of drugs such as metformin or acarbose under medical oversight. They also cite practical steps already backed by CGM studies, including eating protein and vegetables before starch and taking a brief walk after meals. Still, the authors concede that CGM is best viewed now as a teaching tool for a few weeks, not as a validated risk test for healthy people.

Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.